Navigation Links
UH Case Medical Center Offers New Therapy for Gynecologic Cancer Patients
Date:1/20/2012

CLEVELAND, Jan. 20, 2012 /PRNewswire/ -- Patients with gynecologic cancer have new hope in a novel technology now offered at the Seidman Cancer Center at University Hospitals (UH) Case Medical Center.  A team of cancer specialists, led by Robert DeBernardo, MD, is among the first in the nation to launch a dedicated program using Hyperthermic Intraperitoneal Chemotherapy (HIPEC) to treat ovarian, endometrial and select other cancers.

Performed immediately following surgery, HIPEC delivers heated chemotherapy through a 'hot bath' into the abdominal cavity, where it can penetrate diseased tissue directly.  After the surgeon removes as much visible cancer as possible, a heated, a sterilized chemotherapy solution is circulated throughout the abdomen through a technologically sophisticated perfusion system to destroy the remaining cancer cells. 

"This is a new and potentially revolutionary way of treating women with gynecologic cancers, which tend to be quite responsive to chemotherapy," says Dr. DeBernardo, gynecologic oncologist at UH Case Medical Center and Assistant Professor at Case Western Reserve University School of Medicine. "Our preliminary data and experience has been overwhelmingly positive and the therapy has been well-tolerated and effective. HIPEC promises to extend lives in a meaningful way."   

HIPEC has been used for years in patients with colon, pseudomyxomas and appendiceal cancers as well as mesothelioma, cancers that in general are not responsive to chemotherapy, but it is now viewed as a promising new treatment for gynecologic malignancy.  

UH Case Medical Center plans to launch several Phase One trials for patients this spring, including a first-of-its kind study involving the use of heated chemotherapy for ovarian cancer that has spread to the thoracic cavity, a procedure called Hyperthermic Intrathoracic Chemotherapy (HITEC). These hard-to-treat cancers typically recur an
'/>"/>

SOURCE University Hospitals
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. First Choice Rehabilitation Specialists Joins Select Medical
2. inVentiv Health to Acquire SDI Promotional and Medical Audit Businesses From IMS Health
3. Scott Brooks Joins Regenesis Biomedical as Chief Operating Officer
4. Saladax Biomedical, Inc. Issued Six Patents Containing Broad Claims in the Immunoassay Space
5. Live Press Briefing on Findings of Biomedical Industry CEO Survey
6. Saladax Biomedical, Inc. to Present at Biotech Showcase™ 2012
7. HealthCare Institute of New Jersey Releases 2011 Biopharmaceutical and Medical Technology Economic Impact Data
8. Varian Medical Systems Schedules First Quarter FY2012 News Release and Conference Call
9. China Sky One Medical to Jointly Launch Adult Stem Cell Research Enterprise
10. Breaking Study: ICU Medicals Tego® Needlefree Connector Proves More Cost Effective Than Traditional Central Venous Catheter Locks
11. Van Andel Institute Partners with UNCF to Recruit Students to Biomedical Research Careers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... Achieved primarily through a proprietary paraffin and stain ... 100x better detail than the industry standard. But ... microscopy methods, it needed another medium to measure its ... of reference because it represents the highest standard of ... earliest discovery days of Ultralight Histology was to reverse ...
(Date:5/4/2015)... 2015 - New Massive Open ... prepare for the United States Medical Licensing Examination ... technical and medical information products and services, announced today ... Online Course) designed to help medical students prepare for ... the first and most daunting of the three exams ...
(Date:5/4/2015)... ALISO VIEJO, Calif. , May 4, 2015 /PRNewswire/ ... to eliminate preventable hospitalizations, has teamed with the ... effect of Sentrian technology on 1,000 patients with chronic ... nearly 13 million Americans and is the nation,s third ... plan members of CareMore Health System , a ...
(Date:5/1/2015)... OncoTAb, Inc., a University of ... that Pinku Mukherjee, Ph.D. has received the O. ... highest faculty honor. Mukherjee received the award, which recognizes ... innovative research and development of cancer diagnostics and treatments. ... moment in my scientific career,” said Mukherjee, OncoTAb Co-founder ...
Breaking Biology Technology:Elsevier's Free MOOC Prepares Med Students for Licensing Exam 2Elsevier's Free MOOC Prepares Med Students for Licensing Exam 3CareMore, Scripps Translational Science Institute, and Sentrian Launch Landmark Study of Remote Patient Monitoring for COPD Population 2CareMore, Scripps Translational Science Institute, and Sentrian Launch Landmark Study of Remote Patient Monitoring for COPD Population 3CareMore, Scripps Translational Science Institute, and Sentrian Launch Landmark Study of Remote Patient Monitoring for COPD Population 4CareMore, Scripps Translational Science Institute, and Sentrian Launch Landmark Study of Remote Patient Monitoring for COPD Population 5OncoTAb CSO Awarded the University of North Carolina’s O. Max Gardner Award 2
... LUND, Sweden, January 18 ,ThromboGenics NV (Euronext ... (Nordic Exchange: BINV) announce today that they,have ... Denmark to,initiate a Phase I clinical trial ... a monoclonal antibody that targets the angiogenic ...
... Calif. University of California, Irvine researchers have identified ... cerebral cortex, a finding that could lead to stem ... as stroke and Alzheimers. , Dr. Edwin Monuki, doctoral ... of Pathology & Laboratory Medicine and Developmental & Cell ...
... last 12 ... months, ... the global leader in,pharmaceutical services will open an office in Wilmington, N.C. ... development., The new Wilmington office is Quintiles, second expansion within the,state ...
Cached Biology Technology:ThromboGenics and BioInvent Receive Approval to Begin Clinical Trials of TB-403 for the Treatment of Cancer 2ThromboGenics and BioInvent Receive Approval to Begin Clinical Trials of TB-403 for the Treatment of Cancer 3ThromboGenics and BioInvent Receive Approval to Begin Clinical Trials of TB-403 for the Treatment of Cancer 4ThromboGenics and BioInvent Receive Approval to Begin Clinical Trials of TB-403 for the Treatment of Cancer 5Discovery of 'creator' gene for cerebral cortex points to potential stem cell treatments 2Quintiles to Open Clinical Research Office in Wilmington, NC 2
(Date:3/24/2015)... DUBLIN , Mar. 24, 2015 Research and ... addition of the "Global Iris Recognition Market 2015-2019" ... forecast the Global Iris Recognition market to grow at ... This report covers the present scenario and ... for the period 2015-2019. To calculate the market size, ...
(Date:3/24/2015)... BEACH GARDENS, Fla. , March 24, 2015 ... biometric identity management solutions, today announced that its ... premium clothing accessory retailer Goorin Bros . ... The Crossmatch biometrics-based solution secures access to the ... from the increased risk of data breaches. ...
(Date:3/23/2015)... -- In the 2014 fiscal year, irs.gov recorded over $100 ... accounts for a fraction of the estimated losses for ... $11 billion globally. The polygraph has traditionally been used ... Investor Mark Saint Juste along with former ... partnered to administer the test in a new way: ...
Breaking Biology News(10 mins):Global Iris Recognition Market 2015-2019 with 3M Cogent, Bioenable Technologies, Cross Match Technology, Iris ID Systems & Safran Dominating 2Crossmatch Fingerprint Readers Help Retailer Prevent Data Breaches at Point-of-Sale 2Polygraph Test Now Used to Protect Investors From Fraud 2Polygraph Test Now Used to Protect Investors From Fraud 3
... that a fundamental building block in the cells ... on a separate branch of the evolutionary tree--in ... at least 420 million years ago. ... the group that includes conifers, ginkgos and related ...
... Geneticists of Leiden University Medical Centre (LUMC) are the ... She is also the first European whose DNA sequence ... researchers this morning, during a special press conference at ... in the Netherlands. Following in-depth analysis, ...
... of the Watson School of Biological Sciences, has been ... Dr. Joshua-Tor, a structural biologist whose work ... new HHMI Investigators selected from among 1,070 applicants. They ... who lead Hughes laboratories at 64 institutions. At ...
Cached Biology News:When plants 'think' alike 2Leiden scientists sequence first female DNA 2Leemor Joshua-Tor, PhD, CSHL biologist and WSBS dean, is named an HHMI Investigator 2Leemor Joshua-Tor, PhD, CSHL biologist and WSBS dean, is named an HHMI Investigator 3
Rabbit anti Xanthine Oxidase Xanthine Oxidase, Bovine Buttermilk...
... system uses three Adept CE 4100 high ... flow rate in one microlitre increaments. ... detector, provides added flexibility. The ... photodiode array detection and provides superior stability ...
... range has now been expanded ... quaternary low pressure mixing pump ... mixing pump. These space ... even more versatility to modular ...
...
Biology Products: